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Abstract This study intends to improve blood compati-
bility of polysulfone (PSF) membranes by generating a
nonthrombogenic surface through heparin immobilization.
To achieve this task, the support membrane prepared from
a blend of PSF and sulfonated polysulfone (SPSF) was
modified with layer by layer (LBL) deposition of poly-
ethyleneimine (PEI) and alginate (ALG) and heparin
blended with ALG was immobilized only on the outermost
surface of the LBL assembly. The results have shown that
the adsorption of human plasma proteins and platelet
activation on the LBL modified membranes decreased
significantly compared with the unmodified PSF and PSF-
SPSF blend membranes. Furthermore, blending ALG with
a small amount of heparin remarkably prolonged the APTT
values of heparin free PEI/ALG coated membranes. It is
envisaged that the use of a blend of HEP and ALG only in
the terminating layer of the LBL assembly can be an
economical and alternative modification technique to cre-
ate nonthrombogenic surfaces.
1 Introduction
Extracorporeal thrombosis is a major problem of hemodi-
alysis operation leading to embolism and infarction. To
prevent this problem, blood anticoagulant heparin is usu-
ally injected during hemodialysis. However, using large
amount of heparin can increase the risk of abnormal
bleeding and heparin induced thrombocytopenia. In recent
years, researchers focused on producing nonthrombogenic
materials to provide heparin-free hemodialysis. The most
commonly used approach is to mimic endothelial cell layer
by heparin immobilization. The beneficiary effect of hep-
arin coatings on the membranes has been reported by many
authors both in vitro [1–9] and in vivo [10–15]. For
example, Cheung et al. [1] observed that complement
activation induced by hemodialysis can be modulated with
heparin immobilized cellulose acetate membrane. Bau-
mann and Kokott [2] immobilized endothelial cell surface
heparin sulfate (ESHS) on polysulfone (PSF), polycar-
bonate and polyurethane membranes and they found that
the coating of these membranes by ESHS allows to gen-
erate surfaces resistant to platelet adhesion and have no
effects on complement and intrinsic coagulation cascade
activation. Yang and Lin [3, 4] and Lin et al. [5] covalently
bonded chitosan/heparin conjugate onto the surface of PAN
and PSF membranes and they reported improved biocom-
patibility of these membranes by evaluating coagulation
time, plasma protein adsorption capacity and platelet
adhesion [1–5]. Zhu et al. [6], Jiang et al. [7] and Huang
et al. [8, 9] also improved blood compatibilities of the
poly(vinylidene fluoride), polyethylene (PE) and PSF
membranes by covalent attachment of heparin [6–9].
In vivo tests carried out with commercial hemodialysis
membranes, AN69 ST, HEMOPHAN and EVODIAL
showed that it is possible to reduce systemic administration
of heparin through its immobilization on these membranes
[10–15]. On the other hand, one clinical study reported that
heparin coated AN69 ST membrane does not reduce clot-
ting during hemodialysis when compared to a conventional
PSF filter [16]. In most of these studies, heparin was
covalently attached to the surfaces, on the other hand, ionic
binding was also used for immobilization [10, 12–14, 16].
Recently, the layer by layer self-assembly (LBL) technique
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has emerged as a versatile, gentle and easy surface modi-
fication method for immobilization of functional mole-
cules. The assembly process can be conducted in an
aqueous solution under mild ambient conditions which
minimize the loss in the activity of biological agents due to
attachment on a surface. Electrostatic interactions are most
often used to drive multilayer assembly, however, other
interactions such as hydrogen bonding, hydrophobic
interactions and molecular recognition can also be applied
for constructing the assembly [17]. The LBL method can
be utilized for all types of multifunctional and mutually
interacting species and the strength of interactions between
interacting species can be easily adjusted to minimize
desorption of the functional molecules on the surface of the
assembly. The method was used to improve biocompati-
bility of blood-contacting materials. For example, platelet
adhesion/activation and leukocyte adhesion on polyether-
sulfone hemodialysis membrane were significantly reduced
with the LBL deposition of heparin and albumin on the
surface of this membrane [18].
This study intends to improve hemocompatibility of PSF
based hemodialysis membranes through heparin (HEP)
immobilization. To achieve this task, first the support
membrane was prepared from a blend of PSF and sulfo-
nated polysulfone (SPSF) and modified with layer by layer
(LBL) deposition of polyethyleneimine (PEI) and alginate
(ALG). Then, heparin was immobilized only on the out-
ermost surface of the LBL assembly by blending with
ALG. In previous studies, heparin was used alone to adsorb
on positively charged polyelectrolytes for each alternating
layer. In our study, small amount of HEP was blended with
another polyanion, ALG, to form the outermost layer of the
assembly. The intermediate layers were prepared with the
alternate deposition of the PEI and heparin free ALG. The
scientific motivation of this work is to investigate the
anticoagulant activity and biological properties of HEP
when blended with another polyanion, ALG. We compare
the hemocompatibilities of the PSF and polysulfone-
sulfonated polysulfone (PSF-SPSF) membranes with those
of the corresponding membranes modified with PEI/ALG
and PEI/ALG-HEP coatings. The blood compatibilities of
fabricated membranes were evaluated in terms of amount
of adsorbed plasma proteins, the activated partial throm-
boplastin time (APTT), platelet adhesion, activation and
cytotoxicity on blood cells. In addition, the transport,
structural and mechanical properties of the membranes
were also characterized. To the best of our knowledge, this
is the first study which investigates the heparin immobili-
zation on the PSF based hemodialysis membranes with the
LBL assembly. In addition, in previous studies the benefit
of blending heparin with another polyanion to improve
hemocompatibility of the hemodialysis membranes was not
illustrated.
2 Materials and Methods
2.1 Materials
Polysulfone with a molecular weight of 26,000 g mol-1,
1-2 dichloroethane, chlorosulfonic acid, sodium dodecyl-
sulfate (SDS) were purchased from Aldrich, 1-methyl-2-
pyrrolidone (NMP) with a purity of 98 % and micro
BCA protein assay reagent kit were purchased from Fluka
and Thermoscientific, respectively. Heparin, bovine serum
albumin (MW 65000), urea, vitamin B12, lysozyme were
all supplied by Sigma. Cell viability kits, thiazole orange
(TO) and propidium iodide (PI), and the monoclonal
antibodies, PAC1, FITC and CD62 PE, which were used
for determination of platelet activation were purchased
from Becton-Dickinson Immunocytometry Systems.
H2NaPO4 and Na2HPO4 used for preparing buffer solu-
tions were obtained from Fluka and Riedel, respectively.
Water was distilled ion-exchanged water. Whole blood
was taken from a healthy single donor and the ethics
committee approval for the experiments with blood cells
was obtained.
2.2 Preparation of the membranes
The conventional PSF has no functional groups and char-
ges, thus, it was first modified by sulfonation to induce
negatively charged groups (SO3
-) before preparing the
support membrane [19]. To prepare the PSF and PSF-SPSF
blend membranes, a solution of 20 wt% of PSF or 10 wt%
of PSF and 10 wt% of SPSF in N-methyl pyrrolidone was
cast onto a 10 9 24 cm glass substrate, respectively with
the aid of an automatic film applicator (Sheen Instrument
Ltd., model number: 1133 N) at a speed of 100 mm s-1.
The initial thickness of the cast film was adjusted by a four
sided applicator with a gap size of 150 lm. Following
casting, the support was transferred into an environmental
chamber (Angelantoni Industrie, Italy, Challenge Series,
model number: CH250) in which the solution was dried for
2 min under 25 C temperature and 40 % relative humid-
ity. Then, it was immediately immersed in a coagulation
bath for 18 h, and rinsed with pure water for 1 h. The
membranes were allowed to dry further for a period of 72 h
in a vacuum oven maintained at 100 C. They were then
kept in a desiccator until their use.
The LBL assembly was formed on the negatively
charged PSF-SPSF blend membrane. For this purpose, this
membrane was first dipped in a 0.1 mg ml-1 of cationic
macromolecule, PEI solution for 10 min. The pH of the
PEI solution was adjusted by HCl to a value of 8, under its
isoelectric point, to obtain a sufficiently protonated form,
hence, to ensure its strong bonding on the negatively
charged membrane surface through electrostatic attraction.
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To remove excessive PEI on the surface of the self-
assembled layer, the membrane was rinsed with 500 ml
water for 10 min and then immersed in a 1 mg ml-1 of
ALG solution at pH 7.4 and 4 C for 24 h. Loosely-bound
ALG was washed away under same conditions as described
above. The dipping in alternating PEI and ALG solutions
and rinsing after each removal were repeated five times to
build intermediate layers of multilayer assembly on the
support membrane. Heparin was immobilized only on the
outermost layer of this assembly by blending with ALG at
a concentration of 15 and 45 wt%. The preparation con-
ditions and codes of the membranes prepared are listed in
Table 1.
2.3 Surface characterization
Contact angle measurements for distilled water were car-
ried out with Attension Optical tensiometer by means of a
horizontal microscope, equipped with a video camera
which is connected to a computer. The volume of liquid
drop varied between 3 and 5 ll. The contact angle was
calculated from the droplet screen image. Each reported
contact angle measurement represents an average value of
fifteen separate drops on different areas of the membranes
obtained from three different batches.
In order to identify the change in surface charge of the
membrane due to polyelectrolyte deposition, the specific
staining of the membrane was used. The negatively
charged groups (carboxyl, hydroxyl and sulfonate groups)
on the membrane can form complexes with toluidine blue
O dye at pH 10 and the positively charged groups (amine
groups) with congo red at pH 7. The staining was per-
formed by dipping the membranes in a 30 ppm solution of
the dye dissolved in its associated solvent for ca. 30 min,
followed by washing the sample with its solvent until the
solvent became colorless [3]. The amount of the charged
groups on the membranes stained with toluidine blue O and
congo red was determined spectrophotometrically in visi-
ble region (Aventes-Avemouse62). Intensity of each color
resulting from adsorption of dyes on the membranes was
reported as an average of ten measurements.
The layer-by-layer deposition of polyelectrolytes was
followed by attenuated total reflectance Fourier transform
infrared spectroscopy (ATR-FITR) (64 scans, 4 cm-1 res-
olution, wavenumber range 4,000–550 cm-1) measure-
ments. Aqueous solutions of PEI and ALG-HEP were
prepared in the same manner as the multilayer dipping
solutions and each solution was cast onto a ZnSe substrate
and dried to leave a pure polymer film for FTIR
characterization.
To determine the surface roughness of the membranes, a
topographical map of the membrane surfaces was obtained
with atomic force microscopy (AFM) on a Nanomagnetics
Instrument model. 5 9 5 lm surface was scanned with
512 9 512 pixel resolution using a silicon tip attached to a
cantilever, while maintaining a constant force between the
tip and the sample.
The bulk morphology of the membranes was examined
by scanning electron microscopy (SEM) on a FEI-Quanta
250 FEG model. The samples were coated with gold using
a Magnetron Sputter Coating Instrument.
2.4 Protein adsorption experiments
Protein adsorption experiments were performed with
(i) blood plasma proteins obtained from 50 % platelet poor
plasma (PPP) (ii) model protein, bovine serum albumin
(BSA). The membranes (1.5 9 1.5 cm) equilibrated in
0.05 M, pH 7.4 phosphate buffer at 37 C for 15 h, were
first placed onto a 24-well plate. 1.0 ml of protein solution
(PPP or BSA solution with a concentration of 4.5 mg ml-1)
was poured onto membranes and allowed to remain at
37 C for 1 h. After rinsing three times with PBS, they were
removed from the well plate and rinsed again sufficiently
Table 1 Codes of the
unmodified and modified PSF
membranes prepared
Membrane
code
# of
bilayer
Polyanion type
in the middle
layers
Polyanion
type in the
last layer
Heparin concentration
in ALG-HEP
mixture (wt%)
PSF 0 – – –
PSF-SPSF 0 – – –
PEI/ALG-1b 1 ALG ALG 0
PEI/ALG-5b 5 ALG ALG 0
PEI/ALG-HEP-15-1b 1 ALG ALG-HEP 15
PEI/ALG-HEP-15-5b 5 ALG ALG-HEP 15
PEI/ALG-HEP-45-1b 1 ALG ALG-HEP 45
PEI/ALG-HEP-45-5b 5 ALG ALG-HEP 45
PEI/ALG-HEP-100-1b 1 ALG HEP 100
PEI/ALG-HEP-100-5b 5 ALG HEP 100
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with 50 ml of PBS in order to remove loosely-bond protein.
Each membrane sample treated with protein was placed into
a glass bottle containing 1 wt% aqueous solution of SDS
and shaken (150 rpm) in a shaking bath for 3 h at room
temperature to detach the adsorbed protein on the surface.
In order to take into account an interference which may be
caused by SDS, membrane samples not treated with protein
was used as a proper control. A protein analysis kit (Micro
BCA protein assay reagent kit, #23235, Pierce, Rockford,
IL, USA) based on the bicinchoninic acid (BCA) method
was used to determine the protein concentration in the SDS
solution. The absorbance of the solution at 562 nm was
measured by a spectrophotometer (Perkin Elmer Model No:
Lambda 45). The fresh blood collected with citrated tubes
from healthy volunteer was centrifuged at 2,800 rpm for
15 min at room temperature to obtain platelet poor plasma.
2.5 Platelet and blood cell adhesion and activation
In order to analyze the platelet activation, unmodified and
modified PSF membranes were incubated with acid citrate
dextrose (ACD)-whole blood at 37 C for 25 min. 5 lL of
whole blood suspension was carefully added to the bot-
tom of all tubes and platelet activation-dependent mono-
clonal antibodies of PAC1, FITC and CD62 PE were
added. Specificity of PAC1 binding is demonstrated by
staining in the presence of RGDS peptide (a competitive
inhibitor) as the negative control tube. Without vortex
mixing, the tubes were gently mixed and incubated in the
dark for 15 to 20 minutes at room temperature. Following
the incubation period, 1 mL of cold 1 % paraformalde-
hyde was added to each tube and they were finally stored
at 2–8 C in the dark for at least 2 hours. The percentage
of activated platelets was counted by Flow Cytometer
(BD FacsCanto).
The platelet and blood cell adhesion on the membrane
surfaces was determined by incubating the samples at
37 C with platelet rich plasma (PRP) and heparinized
fresh human blood for 25 and 15 min, respectively. After
incubation, the samples were gently washed to remove
loosely bound platelets and blood cells, fixed with glutar-
aldehyde (2.5 % in 0.1 M sodium cacodylate buffer, pH
7.2) for 30 min at 4 C, and rinsed three times with PBS
buffer (0.1 M, pH 7.4). The samples were then dehydrated
in graded ethanol series (30, 50, 70, 90, and 100 %,
500 mL each) for 10 min each and air dried. Finally, they
were sputtered with gold and analyzed with SEM (FEI-
Quanta 250 FEG).
2.6 Blood coagulation time
Blood coagulation time was measured by APTT. The
sample membrane (1 9 1 cm2) was put in a glass tube,
100 ll of actin activated cephaloplastin reagent (Dade
Behring Inc., USA) was added, and the tube was incubated
at 37 C for 1 min. Then, 100 ll of PPP solution was
added to the sample solution at 37 C, it was incubated for
30 min, and finally 100 ll of 0.025 M CaCl2 solution was
added. The clotting time of the plasma solution was
recorded at the first sign of fibrin formation [3].
To determine stability of immobilized HEP under typi-
cal hemodialysis conditions, blood coagulation time
(APTT) was measured in the same manner, after the
membranes were immersed into 10 mL of 0.05 M phos-
phate buffer solution at pH 7.4 and 37 C. The solution was
stirred thoroughly and the membrane samples were
removed from the solution after 240 min.
2.7 Cell viability assay
To determine toxic effects of the membranes, peripheral
blood mononuclear cells (PBMCs) were isolated from the
sample of healthy human blood by using ficol hypec
gradient centrifugation. The membranes (1.5 9 1.5 cm)
were placed in 96 well-plate with 200 ll PBMCs sample
and maintained at 37 C for 4 h. The number of live and
dead cells were determined with Flow cytometer (BD
FacsCanto). For labeling live and dead cells; Thiazole
Orange (TO) and Propidium Iodide (PI) were used,
respectively.
2.8 Permeation experiments
Permeation experiments were carried out in a side by side
diffusion cell (Permegear Membrane Transport Systems)
using urea, vitamin B12 and lysozyme as model solutes.
Samples were removed from each chamber at given time
intervals and concentration of myoglobin and vitamin B12
were determined by directly measuring their natural
absorbance at 409 and 360 nm, respectively. The concen-
tration of urea was determined by first adding an enzymatic
reagent (BT Product, Turkey) and then reading the absor-
bance of this mixture at 340 nm. The overall mass transfer
coefficient which has contributions both from the bulk fluid
and the membrane was evaluated from the solute concen-
tration data [20]. The effective permeability of the solute
was determined from the overall and individual mass
transfer coefficients [20].
2.9 Data analysis
The data were analyzed with the statistical software
Minitab 15 using Student’s paired t test. The probability
(P) values P \ 0.05 were considered to be statistically
significant differences. The results were expressed as
mean ± standard error.
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3 Results and discussion
3.1 Surface characterization of the membranes
The first surface characteristic of the membranes investi-
gated was their hydrophilicity since it plays an important
role in thrombogenesis [21]. The hydrophilicity was
determined through contact angle measurements and the
results are shown in Fig. 1. It is seen that the hydrophilic
character of the PSF membrane was remarkably improved
by blending PSF with SPSF and depositing polyelectrolyte
layers on the PSF-SPSF membrane as observed by a
decrease in the contact angle values. Increasing the number
of polyelectrolyte layer or the HEP concentration in the
ALG-HEP blend solution did not change the contact
angles.
The surface charge of the membranes was determined
by the staining technique. The results in Fig. 2 illustrate
that all the PEI/ALG or PEI/ALG-HEP coated membranes
were significantly stained with basic toluidine blue o dye.
The intensity of blue colour compared to that of red colour
was found much higher. This simply indicates that the net
charges of the PSF-SPSF and all the polyelectrolyte
deposited membranes are negative.
Figure 3a shows the FTIR spectra of ALG and ALG-
HEP in the form of the multilayer films. ALG layer consists
of two distinct adsorption bands of the carboxylic acid
functional groups; v = 1,565–1,542 cm-1 (asymmetric
stretching band of COO-) and v = 1,710–1,700 cm-1
(C=O stretching of COOH). In the case of ALG-HEP layer,
S–O stretching modes of SO3 groups in HEP was also seen
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centered at 1,230 cm-1. Asymmetric NH3? bending band
of PEI at 1,630 cm-1 overlaps with the adsorption bands of
the carboxylic acid functional groups in ALG-HEP layer.
To solve this problem, each band of ALG-HEP and PEI was
deconvoluted by assuming a Gaussian distribution and
using Microcal Origin software (Fig. 3b). The band inten-
sity was estimated from the maximum peak height of each
adsorption band. The degree of ionization of ALG-HEP
layer in 1 and 5 bilayer multilayer formation was calculated
from a ¼ cCOO
 
cCOO þ cCOOH
 
assuming the same
extinction coefficients for both bands. As can be seen from
Fig. 3b, almost all of the COOH groups were transformed
into COO– form, hence, the degree of ionization was cal-
culated as 0.99 and 0.97 for 1 and 5 bilayer formation,
respectively. The degree of ionization of ALG and HEP in
the solution has also a similar value (0.99) which indicates
that there is no change in the ionizable groups during
adsorption of these polyelectrolytes. The presence of S–O
stretching modes of SO3 groups at around 1,230 cm
-1,
moreover, the increase of the signal intensity for the
5-bilayer coating compared to the 1-bilayer one shown in
Fig. 3a are clear evidences of the multilayer film formation.
Fig. 4 AFM images of a PSF, b PSF-SPSF and c PEI/ALG-HEP-15-1b membranes
538 J Mater Sci: Mater Med (2013) 24:533–546
123
The average surface roughness of the membranes was
obtained from the analysis of AFM images shown in Fig. 4.
The unmodified PSF membrane had the smoothest surface
while sulfonation significantly increased the surface
roughness. On the other hand, the layer by layer deposition
of PEI/ALG or PEI/ALG-HEP on the surface of PSF-SPSF
improved the smoothness of the surface (Fig. 5). This can
be attributed to the energy-minimization process taken
place on the surface of the deposited film, where PEI
undergoes deformation to minimize the surface area as a
result of enhanced diffusional mobility of linear PEI chains.
The change in the bulk structure of the PSF membrane
through blending with SPSF and polyelectrolyte deposition
was observed with the SEM pictures. Figure 6 shows that
native (PSF) and modified membranes have asymmetric
structures. The PSF-SPSF membrane is more porous than
the PSF membrane, however, these pores were blocked
with polyelectrolytes, therefore, the bulk structures of the
PSF and the 1- and 5-bilayer PEI/ALG-HEP coated
membranes are similar.
3.2 Protein adsorption capacity of the membranes
Plasma protein adsorption on the membrane is the key
phenomena during thrombogenic formation [22], therefore,
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Fig. 6 Cross section SEM pictures of a PSF, b PSF-SPSF, c PEI/ALG-HEP-15-1b, d PEI/ALG-HEP-45-5b membranes. Magnification 10009
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protein adsorption capacities of all the membranes were
determined. The experiments were first performed with a
negatively charged BSA, to represent most of the nega-
tively charged proteins in blood. It is seen from Fig. 7 that
the highest BSA adsorption occured on most hydrophobic
PSF membrane. Blending PSF with SPSF and depositing
polyelectrolytes on the PSF-SPSF blend membrane
reduced protein adsorption by 30 and 51 %, respectively.
Although the PSF membrane has the smoothest surface, the
strong protein binding affinity of this membrane is due to
hydrophobic groups on the surface while less protein
binding to the blend and polyelectrolyte deposited mem-
branes is related to their more hydrophilic character com-
pared to the PSF membrane as shown in Fig. 1. In addition
to hydrophobic interactions, electrostatic interactions are
also effective on the protein adsorption. During protein
adsorption experiments, BSA was negatively charged since
its isoelectric point, pI: 4.9, is lower than the pH of the
solution adjusted to physiological pH 7.4. The PSF mem-
brane has no charged group on the surface, on the other
hand, the PSF-SPSF and the 1- and 5-bilayer PEI/ALG and
PEI/ALG-HEP coated membranes carry negatively
charged –OSO3
- and –COO- groups that can repel BSA
due to electrostatic interactions. The PEI/ALG or PEI/
ALG-HEP coated membranes adsorb less protein than the
PSF-SPSF membrane since their surfaces are much more
smooth. Not only BSA but also blood plasma proteins
adsorbed on the membranes were determined and the
results are shown in Fig. 8. The decrease in the adsorption
of plasma proteins on the membranes due to PEI/ALG or
PEI/ALG-HEP immobilization (*42 %) is not as high as
in the case of BSA adsorption (*51 %). This is expected
since human plasma proteins are a mixture of approxi-
mately 200 kinds with different charge, hydrophobicity and
structure, consequently, their adsorption mechanism is
quite complicated. The results in Figs. 7 and 8 show that all
the polyelectrolyte deposited membranes have similar BSA
and plasma protein adsorption capacities (P [ 0.05). This
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could be attributed to similar hydrophilicity, surface charge
and surface roughnesses of these membranes as shown in
Figs. 1, 2 and 5, respectively.
3.3 Platelet and blood cell activation on the membranes
Platelets play a crucial role in the coagulation by secreting
or releasing prothrombotic factors, therefore, platelet acti-
vation on different membranes was determined. Figure 9
shows that the highest platelet activation occurred on the
PSF and PSF-SPSF membranes, on the other hand, poly-
electrolyte deposition remarkably decreased the activation
(P \ 0.05). All the PEI/ALG and PEI/ALG-HEP coated
membranes did not show significantly different activation
(P [ 0.05). The reduction of platelet activation on the
polyelectrolyte deposited membranes can be attributed to
decreased plasma protein adsorption capacities of these
membranes. Among various proteins in blood, adsorption
and conformational change of fibrinogen is known to reg-
ulate the adhesion and activation of platelets [23]. Better
blood compatibility of the heparin immobilized membranes
(PEI/ALG-HEP) may due to maintenance of the native
conformation of adsorbed proteins [24].
To identify the adherent platelets on the membranes,
scanning electron microscope pictures were also used.
When activation starts, multiple prothrombotic factors are
released and the platelets change from disc to varying
degrees of dendritic shape. It is seen from Fig. 10 that more
(a) (b)
(c) (d)
Fig. 10 The SEM pictures of unmodified and modified PSF membranes after incubating with PRP for 25 min a PSF, b PSF-SPSF, c PEI/ALG-
HEP-15-1b, d PEI/ALG-HEP-45-5b, magnification 20009
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platelets adhered on the PSF and PSF-SPSF membranes
than the PEI/ALG-HEP coated membranes and they had
mainly dendritic shapes indicating the beginning of the
platelet activation.
Figure 11a, b show that not only platelets but also
mononuclear cells attached to the uncoated PSF-SPSF
surface and changed their morphology which is a clear sign
of activation. In contrast, fewer adhered cells were detected
on the PEI/ALG-HEP coated membranes and no signs of
morphology change was observed (Fig. 11c, d) primarily
due to much more smooth surfaces of these membranes and
presence of an anticoagulant agent which is in contact with
blood cells.
3.4 Activated partial thromboplastin time (APTT)
The anticoagulant property of the heparin immobilized
membranes was determined by means of APTT. The
unmodified PSF, PSF-SPSF and PEI/ALG deposited
membranes were used as reference samples. The APTT
values for the samples are listed in Table 2. All heparin
immobilized membranes displayed significantly longer
APTT values than other membranes and the control. In the
absence of heparin, improvement in the APTT values of
the PEI/ALG coated membranes compared with those of
PSF and PSF-SPSF membranes is due to their decreased
protein adsorption capacities and platelet activation.
Fig. 11 The SEM pictures of a–b PSF-SPSF and c–d PEI/ALG-HEP-15-1b membranes after incubating in whole blood for 15 min.
Magnification a–c 10009 and (b–d) 50009
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Increasing the number of polyelectrolyte coated layers did
not change the blood coagulation time (P [ 0.05) since
protein adsorption capacities of these membranes were
similar and heparin mixed with ALG was coated only on
the outermost layer of the assembly. In addition, no sig-
nificant improvement in the APTT values was observed by
increasing the initial concentration of heparin in the
depositing solution first from 15 to 45 % and further to
100 % (P [ 0.05). This simply proves that diluting HEP
with ALG does not cause a decrease in its biological
activity. When HEP is blended with ALG, the surface of
PEI is partly covered by long chained ALG, hence, most of
the active sites of heparin, –OSO3
-, which forms an ionic
bond with the positively charged NH2 groups in PEI can
become free, hence, its biological activity is preserved. The
proposed strategy can be an economical alternative for the
modification of hemodialysis membranes since HEP is an
Table 2 APTT values of the unmodified and modified PSF
membranes
Membrane Type APTT (sec)
Before treatment After treatment
Control 35 ± 3 35 ± 3
PSF-SPSF 37 ± 2 35 ± 5
PEI/ALG-1b 63 ± 5 59 ± 3
PEI/ALG-5b 57 ± 7 52 ± 9
PEI/ALG-HEP-15-1b 195 ± 43 142 ± 43
PEI/ALG-HEP-15-5b 195 ± 43 115 ± 40
PEI/ALG-HEP-45-1b 247 ± 35 195 ± 43
PEI/ALG-HEP-45-5b 221 ± 40 195 ± 43
PEI/ALG-HEP-100-1b 195 ± 43 169 ± 44
PEI/ALG-HEP-100-5b 221 ± 40 142 ± 43
Fig. 12 Live and dead cells labeled with TO and PI after incubating PMBCs with a control, b PSF, c PSF-SPSF and d PEI/ALG-HEP-15-1b
membranes
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expensive compound compared to ALG. In previous
studies, the LBL deposition of HEP with different poly-
electrolytes such as chitosan, collagen, dextrin sulfate and
albumin on different blood-contacting surfaces has been
carried out [18, 25–29]. In these studies, HEP was used
alone not only in the last layer of the assembly but also in
each alternating layer to provide charge reversal of the
polycation layer. Consequently, it is obvious that amount
of HEP used in such assemblies is more than that required
in the assembly proposed in this study.
The APTT values for the membranes after stored in pH
7.4 PBS at 37 C for a period of 4 h were not found sig-
nificantly different from those for the freshly prepared
membranes (P [ 0.05). This result suggests that ionic
bonding of heparin to the surface is sufficiently strong and
most of its anticoagulant activity is stable under typical
hemodialysis conditions.
3.5 Cytotoxicities of the membranes
Cytotoxicities of the unmodified and modified PSF mem-
branes were examined with peripheral blood mononuclear
cells isolated from the sample of healthy human blood.
Figure 12 shows live and dead cells labeled with TO and
PI, respectively and Table 3 lists the percentage of live
cells. The results demonstrated that toxic effects of all the
membranes on the PMBCs are similar (P [ 0.05) and
proposed modification technique does not cause a negative
effect on the nontoxic property of PSF.
3.6 Transport properties of the membranes
The results of permeation experiments showed that the
differences in transport rates of all solutes through bare
PSF membrane, PSF-SPSF blend membrane and PEI/ALG-
HEP coated membranes are statistically insignificant
(P [ 0.05) (Fig. 13). This was an expected result since the
bulk structure of all the membranes were similar as shown
in Fig. 6. Moreover, additional mass transfer resistance due
to polyelectrolyte deposition is rather small since the
increase in the total thickness is negligible. The clearing
performance of the unmodified and modified membranes
for lysozyme and vitamin B12 are comparable with those
of the industrial hemodialysis membranes AN69 (1.5 9
10-12 m2 s-1 for MW = 15,000; 4.0 9 10-11 m2 s-1 for
MW = 1,700) and Cuprophan (1.0 9 10-13 m2 s-1 MW =
15,000; 1.5 9 10-11 m2 s-1 MW = 1,700), reported by
Langsdorf et al. [20].
3.7 Mechanical properties of the membranes
Mechanical properties of the membranes were evaluated in
terms of maximum tensile strength and Young’s modulus
values and the results are listed in Table 4. As expected,
blending PSF with SPSF caused slight decrease in maxi-
mum tensile strength of the PSF membrane. While depo-
sition of 1 bilayer polyelectrolyte on the PSF-SPSF
membrane does not significantly change the mechanical
Table 3 % of live cells after incubating PMBCs with the unmodified
and modified PSF membranes for 4 h
Membrane type Live cell %
Control 99.3 ± 0.5
PSF-SPSF 99.6 ± 0.3
PEI/ALG-1b 98.8 ± 0.2
PEI/ALG-5b 99.8 ± 0.7
PEI/ALG-HEP-15-1b 98.1 ± 0.3
PEI/ALG-HEP-15-5b 98.7 ± 0.5
PEI/ALG-HEP-45-1b 97.9 ± 0.9
PEI/ALG-HEP-45-5b 97.6 ± 1.1
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Fig. 13 The permeation coefficient of urea, vitamin B12 and
lysozyme through the unmodified and modified PSF membranes
Table 4 Mechanical properties of the unmodified and modified PSF
membranes
Membrane type Maximum tensile
stress (MPa)
Young modulus
(MPa)
PSF 2.78 ± 0.22 39.82 ± 5.97
PSF-SPSF 2.25 ± 0.18 50.25 ± 7.54
PEI/ALG-HEP-15-1b 2.04 ± 0.16 43.17 ± 6.48
PEI/ALG-HEP-15-5b 2.96 ± 0.24 45.71 ± 6.86
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properties (P [ 0.05), the maximum tensile strength of the
5 bilayer polyelectrolyte coated membrane (PEI/ALG-
HEP-15-5b) is higher than both the PSF-SPSF and the 1
bilayer polyelectrolyte coated membrane (PEI/ALG-HEP-
15-1b). This can be attributed to elimination of defects on
the surface of the membrane after 5 bilayer coating.
4 Conclusion
In the present work, it was aimed to improve the blood
compatibility of PSF based hemodialysis membranes
through heparin immobilization with LBL technique. In
particular, the feasibility of using a blend of HEP and ALG
in the outermost layer of the LBL assembly instead of
utilizing HEP alone as polyanion in each alternating layer
was tested. The APTT results have shown that diluting
HEP with ALG does not cause a decrease in its biological
activity, moreover, most of its anticoagulant activity is
stable under typical hemodialysis conditions. It is sufficient
to immobilize the HEP only in the terminating layer of the
assembly for providing sufficient anticoagulant activity to
the membranes. Polyelectrolyte deposition reduced the
protein adsorption and the platelet activation on the PSF-
SPSF blend membranes. The PEI/ALG and PEI/ALG-HEP
coated membranes did not show significantly different
activation. While improving the blood compatibility of the
PSF membranes, their desired properties such as nontox-
icity and high permeation rates for toxic compounds were
protected when the LBL assembly was formed on these
membranes. The use of a blend of HEP and ALG proposed
in this study can be an economical alternative for the
modification of hemodialysis membranes since HEP is an
expensive compound. Cost-effective modification of the
hemodialysis membranes is critical since their reuse is
forbidden in most countries. The blend approach can be
extended to other expensive and highly functional bio-
molecules to immobilize on different blood-contacting
devices.
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